Search Ontology:
ChEBI
(2S,3R,4R,5S)-2-[(1R)-1,2-Dihydroxyethyl]-5-[(2S,3R,4R,5S)-2-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxyoxolane-3,4-diol
- Term ID
- CHEBI:150583
- Synonyms
-
- beta-D-galacto-hexofuranosyl-(1->3)-[beta-D-galacto-hexofuranosyl-(1->5)]-alpha-D-galacto-hexofuranose
- Galf(b1-3)[Galf(b1-5)]a-Galf
- WURCS=2.0/2,3,2/[a2112h-1a_1-4][a2112h-1b_1-4]/1-2-2/a3-b1_a5-c1
- Definition
- References
-
- GlyGen:G36631LH
- GlyTouCan:G36631LH
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from (2S,3R,4R,5S)-2-[(1R)-1,2-Dihydroxyethyl]-5-[(2S,3R,4R,5S)-2-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxyoxolane-3,4-diol
Phenotype where environments contain (2S,3R,4R,5S)-2-[(1R)-1,2-Dihydroxyethyl]-5-[(2S,3R,4R,5S)-2-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxyoxolane-3,4-diol
Phenotype modified by environments containing (2S,3R,4R,5S)-2-[(1R)-1,2-Dihydroxyethyl]-5-[(2S,3R,4R,5S)-2-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-4,5-dihydroxyoxolan-3-yl]oxyoxolane-3,4-diol
Human Disease Model